IDH1 and neoplasm: Within FFPE sections, tumor-rich ROIs were selected that either had a high T cell number (up to 94 T cells per region) or no T cells according to immunofluorescent tagging of tumor cells (IDH1-R132H), leukocytes (CD45), and T cells (CD3).